SCHEMBL6508951

SCHEMBL6508951

CC(C)(C)OC(=O)C(Cc1ccccc1)NC1=C(Cl)C(=O)c2ccccc2C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB5 P28074 1/20 0.57
▸ ITGA4 P13612 2/20 0.50
▸ ITGB7 P26010 2/20 0.50
▸ MAPT P10636 4/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ CDC25A P30304 3/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C8 P10632 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ NPR3 P17342 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ POLB P06746 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ HSP90AA1 P07900 3/20 0.46
▸ HKDC1 Q2TB90 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020623 0.79 ITGA4 (0.61) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL10584328 0.79 ITGA4 (0.61) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL10584324 0.79 ITGA4 (0.61) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL6800679 0.76 ITGA4 (0.61) ITGA4ITGB7MAPTALDH1A1CYP3A4
SCHEMBL6800676 0.76 ITGA4 (0.61) ITGA4ITGB7MAPTALDH1A1CYP3A4
SCHEMBL19945248 0.76 ITGA4 (0.61) ITGA4ITGB7MAPTALDH1A1CYP3A4
SCHEMBL19945249 0.76 ITGA4 (0.61) ITGA4ITGB7MAPTALDH1A1CYP3A4
SCHEMBL9327945 0.75 MAPT (0.64) PSMB5MAPTMEN1KMT2AALDH1A1
SCHEMBL6315910 0.74 CYP3A4 (0.54) ITGA4ITGB7MAPTMEN1KMT2A
SCHEMBL23901563 0.74 ITGA4 (0.58) ITGA4ITGB7MAPTALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032794-A1 Diamine derivatives of quinone and uses thereof CLINICAL DATA, INC. 2005-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032794-A1 Diamine derivatives of quinone and uses thereof NQO1, DPYD, NQO2 PSMB5 2819/4885ITGA4 3857/4885ITGB7 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback